Pages that link to "Q36607127"

The following pages link to Transmitted/founder and chronic HIV-1 envelope proteins are distinguished by differential utilization of CCR5. (Q36607127):

Displaying 45 items.

• Identifying Recent HIV Infections: From Serological Assays to Genomics (Q26778001) (← links)
• HIV-1 envelope-receptor interactions required for macrophage infection and implications for current HIV-1 cure strategies (Q26825087) (← links)
• Origin of the transmitted virus in HIV infection: infected cells versus cell-free virus (Q27021279) (← links)
• Bottlenecks in HIV-1 transmission: insights from the study of founder viruses (Q28082862) (← links)
• Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus (Q28551914) (← links)
• Cellular superspreaders: an epidemiological perspective on HIV infection inside the body (Q28657772) (← links)
• Recent Insights into the HIV/AIDS Pandemic (Q30235024) (← links)
• Induction of a Tier-1-like Phenotype in Diverse Tier-2 Isolates by Agents that Guide HIV-1 Env to Perturbation-sensitive, Non-native States (Q30401836) (← links)
• A single-residue change in the HIV-1 V3 loop associated with maraviroc resistance impairs CCR5 binding affinity while increasing replicative capacity. (Q30654651) (← links)
• Antigenicity-defined conformations of an extremely neutralization-resistant HIV-1 envelope spike (Q33620194) (← links)
• Which Antibody Functions are Important for an HIV Vaccine? (Q33772637) (← links)
• Broadly neutralizing antibody VRC01 prevents HIV-1 transmission from plasmacytoid dendritic cells to CD4 T lymphocytes (Q34262089) (← links)
• Defining differential genetic signatures in CXCR4- and the CCR5-utilizing HIV-1 co-linear sequences (Q34267043) (← links)
• Mucosal immunity in the female genital tract, HIV/AIDS (Q34275424) (← links)
• Phenotypic properties of transmitted founder HIV-1 (Q34336058) (← links)
• Distinct HIV-1 entry phenotypes are associated with transmission, subtype specificity, and resistance to broadly neutralizing antibodies (Q34503200) (← links)
• Characterization of HIV-1 envelopes in acutely and chronically infected injection drug users (Q34620235) (← links)
• Selection of unadapted, pathogenic SHIVs encoding newly transmitted HIV-1 envelope proteins (Q34721189) (← links)
• Macrophage infection via selective capture of HIV-1-infected CD4+ T cells (Q34742795) (← links)
• Immune evasion activities of accessory proteins Vpu, Nef and Vif are conserved in acute and chronic HIV-1 infection. (Q35855904) (← links)
• Production of Mucosally Transmissible SHIV Challenge Stocks from HIV-1 Circulating Recombinant Form 01_AE env Sequences (Q35915764) (← links)
• Analysis of Viral Diversity in Relation to the Recency of HIV-1C Infection in Botswana (Q36110367) (← links)
• Delineating CD4 dependency of HIV-1: Adaptation to infect low level CD4 expressing target cells widens cellular tropism but severely impacts on envelope functionality. (Q36298503) (← links)
• Accurate predictions of population-level changes in sequence and structural properties of HIV-1 Env using a volatility-controlled diffusion model. (Q36337888) (← links)
• Signatures in Simian Immunodeficiency Virus SIVsmE660 Envelope gp120 Are Associated with Mucosal Transmission but Not Vaccination Breakthrough in Rhesus Macaques (Q36523998) (← links)
• A Novel Role for the Receptor of the Complement Cleavage Fragment C5a, C5aR1, in CCR5-Mediated Entry of HIV into Macrophages (Q36756266) (← links)
• Use of G-protein-coupled and -uncoupled CCR5 receptors by CCR5 inhibitor-resistant and -sensitive human immunodeficiency virus type 1 variants. (Q36911645) (← links)
• Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design (Q36978861) (← links)
• Lack of prophylactic efficacy of oral maraviroc in macaques despite high drug concentrations in rectal tissues (Q37123335) (← links)
• Linkages between HIV-1 specificity for CCR5 or CXCR4 and in vitro usage of alternative coreceptors during progressive HIV-1 subtype C infection (Q37362368) (← links)
• Frequency and Env determinants of HIV-1 subtype C strains from antiretroviral therapy-naive subjects that display incomplete inhibition by maraviroc (Q37390786) (← links)
• HIV-1 envelope replication and α4β7 utilization among newly infected subjects and their corresponding heterosexual partners (Q37444204) (← links)
• Resistance to type 1 interferons is a major determinant of HIV-1 transmission fitness (Q37612507) (← links)
• Quantifying CD4/CCR5 Usage Efficiency of HIV-1 Env Using the Affinofile System (Q38808224) (← links)
• Establishment of mouse leukemia cell lines expressing human CD4/CCR5 using lentiviral vectors (Q39177873) (← links)
• Development of SHIVs with circulating, transmitted HIV-1 variants (Q41144765) (← links)
• The HIV-1 transmission bottleneck (Q42314454) (← links)
• Nonhuman Primate Models and Understanding the Pathogenesis of HIV Infection and AIDS. (Q46243818) (← links)
• HIV-1 adaptation studies reveal a novel Env-mediated homeostasis mechanism for evading lethal hypermutation by APOBEC3G. (Q55033661) (← links)
• Variable infectivity and conserved engagement in cell-to-cell viral transfer by HIV-1 Env from Clade B transmitted founder clones (Q58591002) (← links)
• Evolutionary view of the AIDS process (Q58794804) (← links)
• Activity and structural analysis of GRL-117C: a novel small molecule CCR5 inhibitor active against R5-tropic HIV-1s (Q64082901) (← links)
• Selective use of primate CD4 receptors by HIV-1. (Q64979797) (← links)
• In vitro replicative fitness of early Transmitted founder HIV-1 variants and sensitivity to Interferon alpha (Q89747793) (← links)
• Evolution of the Envelope Glycoprotein of HIV-1 Clade B toward Higher Infectious Properties over the Course of the Epidemic (Q90646343) (← links)